JP2023545992A5 - - Google Patents
Info
- Publication number
- JP2023545992A5 JP2023545992A5 JP2023520531A JP2023520531A JP2023545992A5 JP 2023545992 A5 JP2023545992 A5 JP 2023545992A5 JP 2023520531 A JP2023520531 A JP 2023520531A JP 2023520531 A JP2023520531 A JP 2023520531A JP 2023545992 A5 JP2023545992 A5 JP 2023545992A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- domain
- receptor
- cell
- hla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063090113P | 2020-10-09 | 2020-10-09 | |
| US63/090,113 | 2020-10-09 | ||
| US202163172383P | 2021-04-08 | 2021-04-08 | |
| US63/172,383 | 2021-04-08 | ||
| PCT/US2021/054302 WO2022076910A1 (en) | 2020-10-09 | 2021-10-08 | Engineered ipsc and armed immune effector cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545992A JP2023545992A (ja) | 2023-11-01 |
| JP2023545992A5 true JP2023545992A5 (OSRAM) | 2024-10-17 |
Family
ID=81125515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520531A Pending JP2023545992A (ja) | 2020-10-09 | 2021-10-08 | 操作されたｉＰＳＣ及び装備された免疫エフェクター細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240033355A1 (OSRAM) |
| EP (1) | EP4225785A4 (OSRAM) |
| JP (1) | JP2023545992A (OSRAM) |
| KR (2) | KR20250161670A (OSRAM) |
| AU (1) | AU2021358110A1 (OSRAM) |
| CA (1) | CA3194850A1 (OSRAM) |
| IL (1) | IL301983A (OSRAM) |
| MX (1) | MX2023004130A (OSRAM) |
| WO (1) | WO2022076910A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10980836B1 (en) | 2019-12-11 | 2021-04-20 | Myeloid Therapeutics, Inc. | Therapeutic cell compositions and methods of manufacturing and use thereof |
| TW202237827A (zh) | 2020-12-03 | 2022-10-01 | 美商世紀治療股份有限公司 | 經基因工程改造之細胞及其用途 |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス，インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
| KR20240013094A (ko) | 2021-03-17 | 2024-01-30 | 마이얼로이드 테라퓨틱스, 인크. | 조작된 키메라 융합 단백질 조성물 및 그의 사용 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016054520A2 (en) * | 2014-10-03 | 2016-04-07 | The California Institute For Biomedical Research | Engineered cell surface proteins and uses thereof |
| US11667691B2 (en) * | 2015-08-07 | 2023-06-06 | Novartis Ag | Treatment of cancer using chimeric CD3 receptor proteins |
| US20190328784A1 (en) * | 2016-07-15 | 2019-10-31 | Poseida Therapeutics, Inc. | Chimeric antigen receptors (cars) specific for muc1 and methods for their use |
| BR112019023608A2 (pt) * | 2017-05-12 | 2020-05-26 | Crispr Therapeutics Ag | Materiais e métodos para células manipuladas e seus usos em imuno-oncologia |
| BR112020010597A2 (pt) * | 2017-12-08 | 2020-10-27 | Fate Therapeutics, Inc. | imunoterapias com o uso de células efetoras derivadas de ipsc intensificadas |
| KR20250048610A (ko) * | 2017-12-22 | 2025-04-09 | 페이트 세러퓨틱스, 인코포레이티드 | 향상된 면역 효과기 세포 및 이의 용도 |
| EP3715368A1 (en) * | 2019-03-28 | 2020-09-30 | Albert-Ludwigs-Universität Freiburg | Chimeric antigen receptors, vectors coding for such receptors and their use in the modification of t cells |
| CN112480263A (zh) * | 2019-09-12 | 2021-03-12 | 普米斯生物技术(苏州)有限公司 | 一种双特异t细胞激活器活化t细胞的设计及其应用 |
-
2021
- 2021-10-08 AU AU2021358110A patent/AU2021358110A1/en active Pending
- 2021-10-08 EP EP21878675.4A patent/EP4225785A4/en active Pending
- 2021-10-08 WO PCT/US2021/054302 patent/WO2022076910A1/en not_active Ceased
- 2021-10-08 JP JP2023520531A patent/JP2023545992A/ja active Pending
- 2021-10-08 KR KR1020257036982A patent/KR20250161670A/ko active Pending
- 2021-10-08 US US18/028,457 patent/US20240033355A1/en active Pending
- 2021-10-08 KR KR1020237015184A patent/KR102883294B1/ko active Active
- 2021-10-08 IL IL301983A patent/IL301983A/en unknown
- 2021-10-08 CA CA3194850A patent/CA3194850A1/en active Pending
- 2021-10-08 MX MX2023004130A patent/MX2023004130A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541441A5 (OSRAM) | ||
| JP2022550899A5 (OSRAM) | ||
| JP2021505131A5 (OSRAM) | ||
| JP2022548943A5 (OSRAM) | ||
| JP2022510207A5 (OSRAM) | ||
| JP2023548467A5 (OSRAM) | ||
| JP2023530704A5 (OSRAM) | ||
| JP2021519061A5 (OSRAM) | ||
| JP2023505206A5 (OSRAM) | ||
| JP2023548829A5 (OSRAM) | ||
| JP7623020B2 (ja) | 同種異系移植のための操作された免疫細胞 | |
| JP7767502B2 (ja) | Ｎｋ阻害性分子を発現する遺伝子改変免疫細胞とその使用 | |
| Maher | Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells | |
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| KR20210018838A (ko) | 유전자 조작된 세포 및 응용 | |
| KR20210126008A (ko) | 세포 면역 치료의 조합 | |
| JP2021501587A (ja) | Ｃｄ３８指向性キメラ抗原受容体構築物 | |
| KR20230137923A (ko) | 신규한 키메라 항원 수용체 및 이의 용도 | |
| US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
| JP2024515920A5 (OSRAM) | ||
| KR20250161670A (ko) | 조작된 iPSC 및 보강된 면역 효과기 세포 | |
| JP2024526237A5 (OSRAM) | ||
| CN115785279A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 | |
| JP2024540237A5 (OSRAM) |